In the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma.
A biotech CEO who comes from the business and investment worlds, Russell now runs Endevica, which is working on a novel therapy for cachexia, a wasting syndrome that accompanies many cancers.
11/10/22 • 20 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/pharmaphorum-podcast-382742/a-new-hope-in-cachexia-and-an-outsiders-view-on-pharma-54571465"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to a new hope in cachexia and an outsider’s view on pharma on goodpods" style="width: 225px" /> </a>
Copy